Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Alain Deroussent"'
Autor:
Camille Hauguel, Sarah Ducellier, Olivier Provot, Nada Ibrahim, Diana Lamaa, Coline Balcerowiak, Boris Letribot, Megane Nascimento, Vincent Blanchard, Laurie Askenatzis, Helene Levaique, Jérôme Bignon, Francesco Baschieri, Cyril Bauvais, Guillaume Bollot, Dolor Renko, Alain Deroussent, Bastien Prost, Marie-Catherine Laisne, Sophie Michallet, Laurence Lafanechère, Sébastien Papot, Guillaume Montagnac, Christine Tran, Mouad Alami, Sebastien Apcher, Abdallah Hamze
Publikováno v:
European Journal of Medicinal Chemistry. 240:114573
A series of quinoline and quinazoline analogs were designed and synthesized as new tubulin polymerization (TP) and histone deacetylases (HDAC) inhibitors. Compounds 12a and 12d showed the best cytotoxicity activities against a panel of human cancer c
Autor:
Shannon Pecnard, Olivier Provot, Abdallah Hamze, Mouad Alami, Bastien Prost, Jérôme Bignon, Alain Deroussent, Rafael Peláez, Marc Diederich, Laura Gallego-Yerga, Ji Yeon Paik
Publikováno v:
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, 2021, 223, pp.113656. ⟨10.1016/j.ejmech.2021.113656⟩
European Journal of Medicinal Chemistry, Elsevier, 2021, 223, pp.113656. ⟨10.1016/j.ejmech.2021.113656⟩
European Journal of Medicinal Chemistry, 2021, 223, pp.113656. ⟨10.1016/j.ejmech.2021.113656⟩
European Journal of Medicinal Chemistry, Elsevier, 2021, 223, pp.113656. ⟨10.1016/j.ejmech.2021.113656⟩
International audience; In this study, a variety of original ligands related to Combretastatin A-4 and isoCombretastatin A-4, able to inhibit the tubulin polymerization into microtubules, was designed, synthesized, and evaluated. Our lead compound 15
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8335c4f49de3f9d2519b04a2938dbcf1
https://hal.science/hal-03349143
https://hal.science/hal-03349143
Autor:
Martin Souce, Mouad Alami, Timothée Naret, Olivier Provot, Paloma F. Varela, Athena Kasselouri, Hélène Levaique, Alain Deroussent, Ilhem Khelifi, Jérôme Bignon, Angelo Paci, Benoît Gigant, Joëlle Dubois, Abdallah Hamze
Publikováno v:
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry, American Chemical Society, 2019, 62 (4), pp.1902-1916. ⟨10.1021/acs.jmedchem.8b01386⟩
Journal of Medicinal Chemistry, 2019, 62 (4), pp.1902-1916. ⟨10.1021/acs.jmedchem.8b01386⟩
Journal of Medicinal Chemistry, American Chemical Society, 2019, 62 (4), pp.1902-1916. ⟨10.1021/acs.jmedchem.8b01386⟩
Journal of Medicinal Chemistry, 2019, 62 (4), pp.1902-1916. ⟨10.1021/acs.jmedchem.8b01386⟩
International audience; We report the synthesis and metabolic and biological evaluation of a series of 17 novel heterocyclic derivatives of isocombretastatin-A4 (iso-CA-4) and their structure-activity relationships. Among these derivatives, the most
Autor:
Lionel Mercier, Alain Deroussent, Fabienne Munier, Clémentine Richard, Dominique Valteau-Couanet, Angelo Paci, Gilles Vassal, Bassim Tou, Jérôme Bouligand, Cedric Orear, Paule Opolon, Romain Kessari, Nicolas Simonnard, Estelle Daudigeos-Dubus
Publikováno v:
Pharmaceutical Research. 33:1913-1922
Busulfan-melphalan high-dose chemotherapy followed by autologous stem cell transplantation is an essential consolidation treatment of high-risk neuroblastoma in children. Main treatment limitation is hepatic veno-occlusive disease, the most severe an
Autor:
Didier Desmaële, Alain Deroussent, Sylvère Durand, Ludivine Le Dret, Angelo Paci, Estelle Daudigeos-Dubus, Charles Skarbek, Adeline Maury, Hubert Chapuis, Patrick Couvreur
Publikováno v:
Journal of Chromatography B. 992:30-35
The antitumor drug, ifosfamide (IFO), requires activation by cytochrome P450 (CYP) to form the active metabolite, 4-hydroxyisfosfamide (4-OHIFO), leading to toxic by-products at high dose. In order to overcome these drawbacks, preactivated ifosfamide
Autor:
Charles Skarbek, Thierry Martens, Alain Deroussent, Eric Le Cam, Didier Desmaële, Catherine Pioche-Durieu, Patrice Renevret, Patrick Couvreur, Sonia Baconnais, Julia Delahousse, Angelo Paci, Michael Rivard
Publikováno v:
International Journal of Pharmaceutics
International Journal of Pharmaceutics, Elsevier, 2017, 532 (2), pp.748-756. ⟨10.1016/j.ijpharm.2017.05.044⟩
International Journal of Pharmaceutics, 2017, 532 (2), pp.748-756. ⟨10.1016/j.ijpharm.2017.05.044⟩
International Journal of Pharmaceutics, Elsevier, 2017, 532 (2), pp.748-756. ⟨10.1016/j.ijpharm.2017.05.044⟩
International Journal of Pharmaceutics, 2017, 532 (2), pp.748-756. ⟨10.1016/j.ijpharm.2017.05.044⟩
Oxazaphosphorines including cyclophosphamide, trofosfamide and ifosfamide (IFO) belong to the alkylating agent class and are indicated in the treatment of numerous cancers. However, IFO is subject to limiting side-effects in high-dose protocols. To c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37025f7804fb19ab3e942c596c157d8e
https://hal.archives-ouvertes.fr/hal-03065099
https://hal.archives-ouvertes.fr/hal-03065099
Autor:
Angelo Paci, Estelle Dubus-Daudigeos, Sonia Martelli, Alain Deroussent, Didier Desmaële, Stéphanie Rodriguez, Atmane Seck, Gilles Vassal
Publikováno v:
Journal of Chromatography B. 879:743-750
Among antitumor oxazaphosphorine drugs, the prodrug ifosfamide (IFO) and its analogs require metabolic activation by specific liver cytochrome P450 (CYP) enzymes to become therapeutically active. New 7,9-dimethyl-ifosfamide analogs have shown greater
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis
Journal of Pharmaceutical and Biomedical Analysis, Elsevier, 2010, 52 (3), pp.391-397. ⟨10.1016/j.jpba.2009.09.014⟩
Journal of Pharmaceutical and Biomedical Analysis, Elsevier, 2010, 52 (3), pp.391-397. ⟨10.1016/j.jpba.2009.09.014⟩
The quaternary benzo[c]phenanthridine alkaloid, sanguinarine (SA), has been detected in the mustard oil contaminated with Argemone mexicana, which produced severe human intoxications during epidemic dropsy in India. Today, SA metabolism in human and
Autor:
Marie Louise Brezniceanu, Hilmar Schiller, James B. Mangold, Helen Gu, Gerhard Gross, Thierry Cresteil, Alain Deroussent
Publikováno v:
The Open Drug Metabolism Journal. 2:14-23
Epothilones are natural macrolides displaying potent antiproliferative properties against various cell lines and capable to bind tubulin and acting as microtubule-stabilizing agents like taxoids. We intended to isolate and characterize epothilone met
Autor:
Thierry Martens, Angelo Paci, Micheline Re, Philippe Bourget, Elise Prost, Gilles Vassal, Lionel Mercier, Jacques Royer, Alain Deroussent, Fabienne Munier, Thomas Storme
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 328:598-609
Ifosfamide is a well known prodrug for cancer treatment with cytochrome P450 metabolism. It is associated with both antitumor activity and toxicities. Isophosphoramide mustard is the bisalkylating active metabolite, and acrolein is a urotoxic side pr